Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with Δ-9-tetrahydrocannabinol

British Journal of Pharmacology

Volumn 125, Issue 7, 1998, Pages 1567-1577

  Hutcheson, Daniel M ^a   Tzavara, Eleni Th ^b   Smadja, Claire ^a   Valjent, Emmanuel ^a   Roques, Bernard P ^a   Hanoune, Jacques ^b   Maldonado, Rafael ^a  

^a INSERM   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Adenylyl cyclase; Cyclic AMP; Physical dependence; Place conditioning; SR 141716A; Tolerance; Withdrawal; 9 tetrahydrocannabinol

Indexed keywords

ADENYLATE CYCLASE; CALMODULIN; DRONABINOL; FORSKOLIN; RIMONABANT;

ABSTINENCE; ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BODY POSTURE; BODY WEIGHT; CEREBELLUM; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG TOLERANCE; HYPOTHERMIA; LOCOMOTION; MALE; MASTICATION; MOTIVATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PTOSIS; REFLEX; TREMOR; WET DOG SHAKES; WITHDRAWAL SYNDROME;

EID: 0031793070     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702228     Document Type: Article

References (72)

1. ACETO, M.D., SCATES, S.M., LOWE, J. & MARTIN, B.R. (1996). Dependence on Δ-9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J. Pharmacol. Exp. Ther., 278, 1290-1295.
2. ADAMS, I.B. & MARTIN, B.R. (1996). Cannabis: pharmacology and toxicology in animals and humans. Addiction, 91, 1585-1614.
3. ANDERSON, P.F., JACKSON, D.M., CHESHER, G.B. & MALOR, R. (1975). Tolerance to the effects of delta-9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity. Psychopharmacologia, 48, 31-36.
4. BECKMANN, A.M., MATSUMOTO, I. & WILCE, P.A. (1995). Immediate early gene expression during morphine withdrawal. Neuropharmacology, 34, 1183-1189.
5. BIDAUT-RUSSELL, M., DEVANE, W.A. & HOWLETT, A.C. (1990). Cannabinoid receptors and modulation of cAMP accumulation in the rat brain. J. Neurochem., 55, 21-26.
6. BOUABOULA, M., POINOT-CHAZEL, C., BOURRIE, B., CANAT, X., CALANDRA, B., RINALDI-CARMONA, M., LE FUR, G. & CASEL LAS, P. (1995). Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CBI. Biochem. J., 312, 637-641.
7. BURSTEIN, S., BUDROW, J., DEBATIS, M., HUNTER, S.A. & SUBRAMANIAN, A. (1994). Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem. Pharmacol., 48, 1253-1264.
8. CADAS, H., GAILLET, S., BELTRAMO, M., VENANCE, L. & PIOMELLI, D. (1996). Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP. J. Neurosci., 16, 3934-3942.
9. CARLINI, E.A., SANTOS, M., CLAUSSEN, U., BIENIEK, D. & KORTE, F. (1970). Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts. Psychopharmacologia, 18, 82-93.
10. CARNEY, J.M., UWAYDAH, I.M. & BALSTER, R.L. (1977). Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol. Biochem. Behav., 7, 357-364.
11. CARR, G.D., FIBIGER, H.C. & PHILIPS, A.G. (1989). Conditioned place preference as a measure of drug reward. In: The Neuropharmacological Basis of Reward. eds. Leibman, J.M. & Cooper, S.J. pp. 264-319. New-York: Clarendon Press.
12. CHEN, J., PAREDES, W., LI, J., SMITH, D., LOWINSON, J. & GARDNER, E.L. (1990). Δ-9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology, 102, 156-162.
13. CHILDERS, S.R., PACHECO, M.A., BENNETT, M.A., EDWARDS, T.A., HAMPSON, R.E., MU. J. & DEADWYLER, S.A. (1993). Cannabinoid receptors: G-protein-mediated signal transduction mechanisms. Biochem. Soc. Snap., 59, 27-50.
14. COMPTON, D.R., ACETO, M.D., LOWE, J. & MARTIN, B.R. (1996). In vivo characterisation of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of Δ-9-tetrahydrocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586-594.
15. DAVIS, W.M., MORETON, J.E., KING, W.T. & PACE, H.B. (1972). Marihuana on locomotor activity: biphasic effect and tolerance development. Res. Commun. Chem. Pathol. Pharmacol., 3(1), 29-35.
16. DEVANE, W.A., DYSARZ III, F.A., JOHNSON, M.R., MELVIN, L.S. & HOWLETT, A.C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol., 34, 605-613.
17. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.A., GRIFFIN, G, GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
18. DEWEY, W.L., HARRIS, L.S., HOWES, J.F., KENNEDY, J.S., GRANCHELLII, F.E., PARS, H.G. & RAZDAN, R.K. (1970). Pharmacology of some marijuana constituents and two heterocyclie analogues. Nature, 226, 1265-1267.
19. DI CHIARA, G., ACQUAS, E. & CARBONI, E. (1991). Role of mesolimbic dopamine in the motivational effects of drugs: brain dialysis and place preference studies. In The Mesolimbic Dopamine System: From Motivation to Aetion. eds. Willner, P. & Scheel-Kruger J. pp. 331-366. London: John Wiley & Sons Ltd.
20. DILL, G.A. & HOWLETT, A.C. (1987). Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. J. Pharmacol. Exp. Ther., 244, 1157-1163.
21. DUMAN, R.S., TALLMAN, J.F. & NESTLER, E.J. (1988). Acute and chronic opiate regulation of adenylyl cyclase in brain: specific and acute effects in locus coeruleus. J. Pharmacol. Exp. Ther., 246, 1033-1039.
22. FAN, F., TAO, Q., ABOOD, M. & MARTIN, B.R. (1996). Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res., 706, 13-20.
23. GARDNER, E.T., PAREDES, W., SMITH, D., DONNER, A., MILLING, C., COHEN, D. & MORRISON, D. (1988). Facilitation of brain stimulation reward by Δ-9-tetrahydrocannabinol. Psychopharmacology, 96, 142-144.
24. HAND, T.H., KOOB, G.F., STINUS, L. & LE MOAL, M. (1988). Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res., 474, 364-368.
25. HARRIS, R.T., WATERS, W. & McLENDON, D. (1974). Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacologia, 37, 23-29.
26. HERKENHAM, M., LYNNE, A.B., LITTLE, M.D., JOHNSON, M.R., MELVIN, L.S., DK COSTA, B.R. & RICE, K.C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A., 87, 1932-1936.
27. HOWLETT, A.C. & FLEMING, R.M. (1984). Cannabinoid inhibition of adenylyl cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol., 27, 429-439.
28. JANSSEN, P., NEIMEGEERS, C. & DONY, J. (1963). The inhibitory effects of fenlanyl (R4263) and other morphine like analgesics, on the warm water induced tail reflex in rats. Arzneimittel-Forsh., 13, 502-507.
29. KOOB, G.F. & LEMOAL, M. (1997). Drug abuse: hedonic homeostatic dysregulation, Science, 278, 52-58.
30. KOZEL, N.J. & ADAMS, E.H. (1986). Epidemiology of drug abuse: an overview. Science, 234, 970-974.
31. LANE-LADD, S.B., PINEDA, J. BOUNDY, V.A., PFEUFFER, T., KRUPINSKI, J., AGHAJANIAN, G.K. & NESTLER, E.J. (1997). CREB (cAMP responsive element binding protein) in the locus coeruleus: biochemical, physiological and behavioral evidence for a role in opiate dependence. J. Neurosci., 17, 7890-7901.
32. LEITE, J.R, & CARLINI, E.A. (1974). Failure to obtain 'cannabis-dirceted behavior' and abstinence syndrome in rats chronically treated with cannabis sativa extracts. Psychopharmacologia, 36, 133-145.
33. LEPORE, M., VOREL, S.R., LOWINSON, J. & GARDNER, E.L. (1995). Conditioned place preference induced by Δ-9-tetrahydrocannabinol comparison with cocaine, morphine, and food reward. Life Sci., 56, 2073-2080.
34. LICHTMAN, A.H. & MARTIN, B.R. (1991). Spinal and supraspinal components of cannubinoid-induced antinociception. J. Pharmacol. Exp. Ther., 258, 517-523.
35. MACKIE, K. & HILLE, B. (1992). Cannabinoids inhibit N-type calcium channels in neuroblastoma x glioma cells. Proc. Natl. Acad. Sci. U.S.A., 89, 3825-3829.
36. MALDONADO, R., BLENDY, J.A., TZAVARA, E., GASS, P., ROQUES, B.P., HANOUNE, J. & SCHUTZ, G. (1996). Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science, 273, 657-659.
37. MALDONADO, R., SAIARDI, A., VALVERDE, O., SAMAD, T.A., ROQUES, B.P & BORRELLI, E (1997). Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature, 388, 586-589.
38. MALDONADO, R., STINUS, L., GOLD, L.H. & KOOB, G.F. (1992). Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther., 261, 669-677.
39. MANSBACH, R.S., NICHOLSON, K.L., MARTIN, B.R. & BALSTER, R.L. (1994). Failure of Δ-9-tetrahydrocannabinol and CPP 55,940 to maintain intravenous self-administration under a fixed-interval schedule in rhesus monkeys. Behav. Pharmacol., 5, 219-225.
40. MANSBACH, R.S., ROVETTI, C.C., WINSTON, E.N. & LOWE III, JA. (1996). Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology, 124, 315-322.
41. MARSHALL, I. & WEINSTOCK, M. (1971). Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration. Nature, 234, 223-224.
42. MARTELLOTA, M.C., COSSU, G., GESSA, G.L. & FRATTA, W. (1998). Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience, 85, 327-330.
43. MARTIN, B.R., DEWEY, W.L., HARRIS, L.S. & BECKNER, J.S. (1976). H-Δ-9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs. J. Pharmacol. Exp. Ther., 196, 128-144.
44. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
45. MATSUOKA, I., MALDONADO, R., DEFER, N., NOEL, F., HANOUNE, J. & ROQUES, B.P. (1994). Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol., 268, 215-221.
46. MATTHES, H.W.D., MALDONADO, R., SIMONININ, F., VALVERDE, O., SLOWE, S., KITCHEN, I., BEFORT, K., DIERICH, A., LE MEUR. M., DOLLE, P., TZAVARA, E., HANOUNE, J., ROQUES, B.P & KEIFFER, B.L. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature, 383, 819-823.
47. MCGREGOR, I.S., ISSAKIDIS, C.N. & PRIOR, G. (1996). Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol. Biochem. Behav., 53, 657-664.
48. MERLO PICH, E.M., LORANG, M., YEGANEH, M., RODRIGUEZ DE FONSECA, F., RABER, J., KOOB, G.F. & WEISS, F. (1995). Increase in extracellular corticotrophin-releasing factor-like immuno-reactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci., 15(8), 5439-5447.
49. 2+ insensitive adenylyl cyclases in the rat brain. Synapse, 14, 51-59.
50. MUCHA, R.F., GRITTI, M.D. & KIM, C. (1986). Aversive properties of opiate withdrawal studied in rats. NIDA Res. Monog., 75, 567-570.
51. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
52. N.I.H. (1995). Guide for the care and use of laboratory animals. N.I.H. Publication, 85/23.
53. PACHECO, M., CHILDERS, S.R., ARNOLD, R., CASIANO, F. & WARD, S.J. (1992). Aminoalkylindoles: actions of specific G-protein-linked receptors. J. Pharmacol. Exp. Ther., 257, 170-183.
54. PARKER, L.A. & GILLIES, T. (1995). THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav. Neurosci., 109, 71-78.
55. PERTWEE, R.G., STEVENSON, L.A. & GRIFFIN, G, (1993). Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br. J. Pharmacol., 110, 1483-1490.
56. POTHOS, E., RADA, P. MARK, G.P. & HOEBEL. B.G. (1991). Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res., 566, 348-350.
57. RAFT, D., GREGG, J., GHIA, J & HARRIS, L. (1976). Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Clin. Pharmacol. Ther., 21(1), 26-33.
58. RASMUSSEN, K., BEITNER-JOHNSON, D., KRYSTAL, J.H., AGHAJANIAN, G.K. & NESTLER, E.J. (1990). Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and bio-chemical correlates. J. Neurosci., 10(7), 2308-2317.
59. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
60. RODRIGUEZ DE FONSECA, F., CARRERA, M.R.A., NAVARRO, M., KOOB, G.F. & WEISS, F. (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid with-drawal. Science, 276, 2050-2054.
61. RUBINO, T., PATRINI, G., MASSI, P., FUZIO, D., VIGANO, D., GIAGNONI, G. & PAROLARO, D (1998). Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G-protein expression. J. Pharmacol. Exp. Ther., 285, 813-819.
62. SANUDO-PENA, M.C., TSOU, K., DELAY, E.R., HOHMAN, A.G., FORCE, M & WALKER, J.M. (1997). Endogenous canabinnoids as an aversive or counter-rewarding system in the rat. Neuroscience Lett., 223, 125-128.
63. SHARMA, S.K., KLEE, W.A. & NIRENBERG, M (1975). Dual regulation of adenylyl cyclase accounts for narcotic dependence and tolerance. Proc. Nail. Acad. Sci. U.S.A., 72, 3092-3096.
64. SHIVACHAR, A.C., MARTIN, B.R. & ELLIS, E.F. (1996). Anandamide and Δ-9-tetrahydrocannabinol-evoked arachidonic acid mobilisation and blockade by SR141716A. Biochem. Pharmacol., 51, 669-676.
65. STARK, P. & DEWS, P.B. (1980). Cannabinoids. I. Behavioral effects. J. Pharmacol Exp. Ther., 214, 124-130.
66. STELLA, N., SCHWEITZER, P. & PIOMELLI, D (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature, 388, 733-778.
67. 1-opioid receptor mechanism. Science, 276, 2048-2050.
68. TSOU, K., PATRICK, S.L. & WALKER, J.M. (1995). Physical withdrawal in rats tolerant to Δ-9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol., 280, R13-R15.
69. TZAVARA, E., POUILLE, Y., DEFER, N. & HANOUNE, J (1996). Diurnal variations of adenylyl cyclase type 1 in the rat pineal gland. Proc. Natl Acad. Sci. U.S.A., 93, 11208-11212.
70. VALVERDE, O., TZAVARA, E., HANOUNE, J., ROQUES, B.P & MALDONADO, R. (1996). Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal. Eur. J. Neurosci., 8, 2671-2678.
71. WISE, R.A. (1996). Addictive drugs and brain stimulation reward. Ann. Rev. Neurosci., 19, 319-340.
72. ZUARDI, A.W., SHIRAKAWA, I., FINKELFARB, E & KARNIOL, I.G. (1982). Action of cannabidiol on the anxiety and other effects produced by Δ-9-tetrahydrocannabinol in normal subjects. Psychopharmacology, 76, 245-250.